Clinical features of headache associated with mobile phone use: a cross-sectional study in university students
© Chu et al; licensee BioMed Central Ltd. 2011
Received: 11 April 2011
Accepted: 26 September 2011
Published: 26 September 2011
Headache has been reported to be associated with mobile phone (MP) use in some individuals. The causal relationship between headache associated with MP use (HAMP) and MP use is currently undetermined. Identifying the clinical features of HAMP may help in clarifying the pathophysiology of HAMP and in managing symptoms of individuals with HAMP. The aim of the present study is to describe the clinical features of HAMP.
A 14-item questionnaire investigating MP use and headache was administered to 247 medical students at Hallym University, Korea. Individual telephone interviews were subsequently conducted with those participants who reported HAMP more than 10 times during the last 1 year on the clinical features of HAMP. We defined HAMP as a headache attack during MP use or within 1 hour after MP use.
In total, 214 (86.6%) students completed and returned the questionnaire. Forty (18.9%) students experienced HAMP more than 10 times during the last 1 year in the questionnaire survey. In subsequent telephone interviews, 37 (97.4%) interviewed participants reported that HAMP was triggered by prolonged MP use. HAMP was usually dull or pressing in quality (30 of 38, 79.0%), localised ipsilateral to the side of MP use (32 of 38, 84.2%), and associated with a burning sensation (24 of 38, 63.2%).
We found that HAMP usually showed stereotyped clinical features including mild intensity, a dull or pressing quality, localisation ipsilateral to the side of MP use, provocation by prolonged MP use and often accompanied by a burning sensation.
The use of mobile phones (MPs) has increased dramatically, with over 3 billion people currently using MPs worldwide . In Korea, 92.9% of the population of approximately 48.4 million people used MPs in 2008 . With the increased use of MPs, some users have reported the development of symptoms such as headache, sleep disturbance, memory loss, dizziness, and burning sensations during or after MP use [3, 4]. Several epidemiological studies have suggested that MP use may be related to the occurrence of these symptoms .
Experiments aimed at explaining these symptoms have shown changes in cerebral blood flow [6, 7], altered electroencephalogram (EEG) patterns [3, 5, 6], and changes in responses to transcranial magnetic stimulation  resulting from MP use. A series of double-blind, sham-controlled studies have reported no significant differences in headache provocation between control and MP radiofrequency fields (RFs) among participants who experienced some of the aforementioned symptoms during MP use [9–15]. Although these studies assessed provocation of headache by RFs similar to those generated by MPs, the relationship between headache provocation and real MP use is currently undetermined [16, 17]. Recent proposals for standardised general diagnostic criteria for the secondary headaches included typical headache characteristics of the presumed causative factors in addition to the temporal relationship of headache and causative factors in onset, worsening and improvement of headache . Identifying the clinical features of headache associated with mobile phone use (HAMP) will help in understanding the pathophysiology of HAMP and in managing symptoms of individuals with HAMP in addition to clarifying the relationship between headache provocation and MP use.
We investigated the first-, second-, and third-year medical students at Hallym University College of Medicine in Chuncheon, Korea. At the time of the initial questionnaire survey, we asked all participants for written signed consent for participation and excluded those students who: (1) declined to participate, (2) did not use MPs, or (3) did not provide written consent for participation. An investigator (CK) who was not involved in medical student education at that time recruited participants and collected signed consent forms.
A 14-item questionnaire was administered to all participants. The questionnaire included 9 items concerning characteristics of HNAMP such as frequency, duration, quality, location and severity of headache; nausea; vomiting; photophobia; and phonophobia (Additional file 1). The questionnaire also included 3 items on the current status of MP use (average daily duration, frequency of MP use and overall duration of MP use) and collected data on the participants' gender and age. An individual was defined as having HAMP if he or she experienced HAMP more than 10 times during the last 1 year.
A neurologist (MKC) conducted semi-structured telephone interviews with respondents who reported that they currently or previously experienced HAMP in the questionnaire survey. The telephone interview included 18 questions on clinical features (onset time, frequency, severity, quality, and location of headache), triggering factors (prolonged MP use, frequent MP use, and other triggering factors), and associated symptoms (burning sensation, dizziness, nausea, vomiting, photophobia, phonophobia, osmophobia and orbital or periorbital pain) of HAMP (Additional file 2).
Categorical variables were summarised by the corresponding percentages, and continuous variables were generally summarised by descriptive statistics (mean and standard deviation [SD]). Between-group differences were evaluated using analysis of variance (ANOVA) after confirming that the data were normally distributed. R version 2.9.1 and R Commander version 1.4-10 statistical software for Windows (GNU general public license) were used for all analyses. The significance of each factor was analysed using 2-tailed p values, where p < 0.05 was considered statistically significant.
A total of 247 medical students at Hallym University College of Medicine were recruited, and 214 students agreed to participate in the study. Two participants did not use a MP at the time of the survey and were thus excluded from the study. All of the remaining 212 participants completed the questionnaire. Their mean age was 23.6 ± 2.6 years; 84 participants (39.6%) were women and 128 (60.4%) were men. In the questionnaire survey, 40 participants indicated that they experienced HAMP more than 10 times during the last 1 year. Of these, 38 participants completed the telephone interview (Figure 1).
Mobile phone use
Duration of daily mobile phone use, frequency of daily mobile phone use, and duration of mobile phone use according to the HAMP status in questionnaire survey.
(n = 40)
(n = 172)
23.88 ± 2.59
23.42 ± 3.14
Female, N (%)
Duration of daily mobile phone use (minutes per day)
31.2 ± 31.4
34.0 ± 35.3
Frequency of daily mobile phone use (number per day)
7.1 ± 5.7
7.4 ± 6.4
Duration of mobile phone use (years)
6.6 ± 6.9
5.3 ± 2.8
Headache not associated with mobile phone use (HNAMP)
Clinical features of headache not associated with mobile phone use (HNAMP).
Headache not associated with mobile phone use, lasing ≥ 30 min.
Moderate or severe intensity
Aggravation of headache by routine activity
Headache associated with mobile phone use (HAMP)
(1) Headache features of HAMP
Among the 212 MP users, 40 (18.9%) participants reported in the questionnaire survey that they experienced HAMP more than 10 times during the last 1 year. Of the 40 participants with HAMP, 38 completed the telephone follow-up interview.
(2) Associated symptoms of HAMP
Associated symptoms of HAMP in telephone interview.
No. of participants (%)
Orbital or periorbital pain
(3) Triggers of HAMP
The present study demonstrated that 18.9% of the participants in the initial questionnaire survey experienced HAMP more than 10 times during the last 1 year. HAMP exhibited mostly stereotyped clinical features such as mild intensity, localisation ipsilateral to the side of MP use, dull or pressing quality, association with a burning sensation, and provocation by prolonged MP use.
These results are similar to those of a study on MP users in Sweden and Norway, in which 8.4-13% of MP users reported HAMP . In Saudi Arabia, HAMP was observed in 22.4% of MP users . Santini et al. reported that 10-20% of MP users complained of HAMP in a questionnaire study conducted in France . Discrepancies in the proportion of MP users who experience HAMP may be due to differences in MP types, demographic features of users, social level of concerns about MP use or media reporting about them . In addition to headache, a burning sensation and dizziness have been commonly observed among MP users. Burning sensation and dizziness accompanying headache were also frequently observed in our study.
Headache during or after MP use could be induced by altering conditions during MP use including radiofrequency fields (RFs), psychological factor, temperature change, noise and various combinations thereof.
Exposure to RFs during MP use has been suggested to trigger a variety of symptoms such as headache, fatigue, concentration difficulties, and nausea . A series of double-blind provocation studies failed to demonstrate a causal relationship between RFs exposure and these symptoms [9, 10, 12–15]. A meta-analysis of 46 blind or double-blind provocation studies reported no robust evidence in support of a connection between RFs exposure and symptoms as a biological entity .
To date, no specific effects of active RFs exposure have been identified, nor has any difference in triggering symptoms been noted between active and sham conditions. Instead, various responses have been observed in repeated exposures of the same participants. Thus, these provocation studies suggest the role of psychological factor, a nocebo effect, in symptom provocation [25–27]. Nocebo effect refers to harmful, unpleasant, or undesirable effects a subject manifests after receiving a sham treatment [26, 28]. In the present study, we used an initial questionnaire survey and subsequent telephone interviews, and did not evaluate psychological factors or nocebo effects associated with HAMP provocation.
Additional altering conditions on subjects during MP use are local temperature change and noise , both of which can provoke headache [30–33]. Local temperature elevation in the area of MP use has been noted in several studies [34, 35]. The sound of a MP is not the same as an actual human voice and usually includes noise . One double-blind cross-over provocation study has taken into account thermal effects of MP use in a provocation test . These investigators used a heated (39 ± 0.2°C) ceramic plate to mimic the sensation caused by using a warm MP during active and sham exposures of RFs. However, they did not investigate whether temperature change during MP use induced symptoms solely or in combination with RFs exposure. The effects of local temperature change and noise in connection with MP use in symptoms triggering by blinded tests were not reported yet. In our study, a burning sensation was reported by 71.1% of participants with HAMP and phonophobia was more prevalent among participants with HAMP compared to those without HAMP. These findings suggest the possibility that local temperature change and/or noise resulting from MP use are associated with HAMP provocation.
Proposals for new standard general diagnostic criteria for secondary headaches include suggestions in evidence of causation of headache: (1) headache has occurred in temporal relationship to the onset of the presumed causative disorder, (2) headache has occurred or has significantly worsening of the presumed causative factors, (3) headache has improved in temporal relation to improvement of the presumed causative factors, (4) headache has characteristics of typical of the causative disorder, (5) other evidence of causation. Evidence of causation of headache is inferred when at least 2 of the aforementioned 5 conditions are met . Regarding the results of our study, HAMP satisfied: (1) temporal relationship to onset of headache (experiencing HAMP more than 10 times during or after MP use), (2) occurring or worsening by worsening of the presumed factor (more individuals experienced HAMP with longer duration of MP use), and (3) characteristics typical of the causative disorder (stereotyped headache features and associated symptoms).
Headache provocation by regular telephone use was reported by only 1 participant with HAMP and HAMP did not occur when using hands-free equipment in the present study. Rare headache provocation by regular telephone use suggests that HAMP is related to certain conditions that are specific to MP use and not to regular telephone use. The lack of HAMP occurrence when using hands-free equipments also suggests that certain factor(s) nullified by hands-free equipments are related to HAMP provocation.
One possible mechanism for headache provocation by regular telephone use was her chronic headache disorder. Her HNAMP occurred 4 days per week with migrainous features (nausea, aggravation by routine physical activity and phonophobia). Clinical features of her HNAMP suggested that she had chronic migraine [37, 38]. Her headache provocation by regular telephone use probably resulted from enhanced sensitivity to environmental stimuli in chronic migraine. The other possible mechanism for her headache provocation by regular telephone use is idiopathic environmental hypersensitivity to electromagnetic fields (IEI-EMF) . However, we did not assess the symptoms during or after using electrical devices other than MP and regular telephone and could not know whether she had IEI-EMF.
Our study has some limitations. First, this study was not a blinded attempt to provoke headache under specific conditions. Instead, we have described the self-reported prevalence and clinical features of HAMP among MP users under actual conditions. Thus, we were not able to evaluate the causal relationship between headache provocation and specific factors related to MP use. Second, the participants in this study were all medical students in Korea. Most of them were 20-30 years of age and used MPs; therefore, our study participants did not reflect the general population. Third, the initial questionnaire survey assessed only the occurrence of headache and HAMP, and we conducted follow-up interviews with only those participants who reported that they were currently experiencing or had previously experienced HAMP. We assessed other MP-associated symptoms such as burning sensation, dizziness, and orbital or periorbital pain during the telephone interviews, but because they were not included in the initial questionnaire survey, we were unable to independently evaluate MP-associated symptoms other than headache among MP users. Fourth, the study was conducted in 2005 when only code division multiple access (CDMA) type MPs were available in Korea. CDMA-type MPs and global system for mobile communication (GSM) type MPs differ in their operating frequency range and electromagnetic filed output power. Thus, the effects of CDMA-type MPs on humans may differ from those of GSM-type MPs. Nevertheless, the prevalence of HAMP among CDMA-type MP users in our study was similar to those of previous reports of HAMP among GSM-type MP users. Fifth, we screened for HAMP by using an initial questionnaire survey in which the participants were asked to recall HAMP during the last 1 year, and there is the possibility of erroneous memory of their headaches. In the present study, most participants with HAMP reported their HAMP occurred frequently during or after MP use (Figure 2). These findings suggest that most participants with HAMP had experienced HAMP recently and might have answered positively in the initial questionnaire survey.
We conclude that HAMP usually presented with stereotyped clinical features such as mild intensity, a dull or pressing quality, localisation ipsilateral to the side of MP use, provocation by prolonged MP use and accompaniment by a burning sensation. Although earlier double-blind RFs provocation tests failed to demonstrate a relationship between HAMP or MP-associated symptoms and RFs exposure, further randomised, controlled provocation studies that examine the effects of altering conditions by MP use including noise, local temperature change, RFs exposure and combinations thereof, are needed in order to better understand the development and nature of HAMP.
List of abbreviations
global system for mobile communication
code division multiple access
headache associated with mobile phone use
headache not associated with mobile phone use
Acknowledgements and funding
The authors would like to express thanks to all participants of this study for their kind cooperation. This study did not receive any financial support.
- Global mobile phone use to pass 3 billion. [http://uk.reuters.com/article/technologyNews/idUKL2712199720070627]
- Mobile phone users passed 45 million in Korea. [http://www.imaeil.com/sub_news/sub_news_view.php?news_id=38300&yy=2008]
- Hocking B, Westerman R: Neurological changes induced by a mobile phone. Occupational Medicine. 2002, 52 (7): 413-415. 10.1093/occmed/52.7.413.View ArticlePubMed
- Roosli M, Moser M, Baldinini Y, Meier M, Braun-Fahrlander C: Symptoms of ill health ascribed to electromagnetic field exposure-a questionnaire survey. International journal of hygiene and environmental health. 2004, 207 (2): 141-150. 10.1078/1438-4639-00269.View ArticlePubMed
- Seitz H, Stinner D, Eikmann T, Herr C, Roosli M: Electromagnetic hypersensitivity (EHS) and subjective health complaints associated with electromagnetic fields of mobile phone communication--a literature review published between 2000 and 2004. Science of the total environment. 2005, 349 (1-3): 45-55. 10.1016/j.scitotenv.2005.05.009.View ArticlePubMed
- Huber R, Treyer V, Borbely A, Schuderer J, Gottselig J, Landolt HP, Werth E, Berthold T, Kuster N, Buck A: Electromagnetic fields, such as those from mobile phones, alter regional cerebral blood flow and sleep and waking EEG. Journal of sleep research. 2002, 11 (4): 289-295. 10.1046/j.1365-2869.2002.00314.x.View ArticlePubMed
- Huber R, Treyer V, Schuderer J, Berthold T, Buck A, Kuster N, Landolt HP, Achermann P: Exposure to pulse modulated radio frequency electromagnetic fields affects regional cerebral blood flow. European Journal of Neuroscience. 2005, 21 (4): 1000-1006. 10.1111/j.1460-9568.2005.03929.x.View ArticlePubMed
- Ferreri F, Curcio G, Pasqualetti P, De Gennaro L, Fini R, Rossini PM: Mobile phone emissions and human brain excitability. Annals of neurology. 2006, 60 (2): 188-196. 10.1002/ana.20906.View ArticlePubMed
- Bamiou DE, Ceranic B, Cox R, Watt H, Chadwick P, Luxon LM: Mobile telephone use effects on peripheral audiovestibular function: a case-control study. Bioelectromagnetics. 2008, 29 (2): 108-117. 10.1002/bem.20369.View ArticlePubMed
- Hietanen M, Hamalainen AM, Husman T: Hypersensitivity symptoms associated with exposure to cellular telephones: no causal link. Bioelectromagnetics. 2002, 23 (4): 264-270. 10.1002/bem.10016.View ArticlePubMed
- Hillert L, Akerstedt T, Lowden A, Wiholm C, Kuster N, Ebert S, Boutry C, Moffat SD, Berg M, Arnetz BB: The effects of 884 MHz GSM wireless communication signals on headache and other symptoms: an experimental provocation study. Bioelectromagnetics. 2008, 29 (3): 185-196. 10.1002/bem.20379.View ArticlePubMed
- Kwon MS, Koivisto M, Laine M, Hamalainen H: Perception of the electromagnetic field emitted by a mobile phone. Bioelectromagnetics. 2008, 29 (2): 154-159. 10.1002/bem.20375.View ArticlePubMed
- Oftedal G, Straume A, Johnsson A, Stovner L: Mobile phone headache: a double blind, sham controlled provocation study. Cephalalgia. 2007, 27 (5): 447-455. 10.1111/j.1468-2982.2007.01336.x.View ArticlePubMed
- Rubin GJ, Hahn G, Everitt BS, Cleare AJ, Wessely S: Are some people sensitive to mobile phone signals? Within participants double blind randomised provocation study. Bmj. 2006, 332 (7546): 886-891. 10.1136/bmj.38765.519850.55.PubMed CentralView ArticlePubMed
- Wilen J, Johansson A, Kalezic N, Lyskov E, Sandstrom M: Psychophysiological tests and provocation of subjects with mobile phone related symptoms. Bioelectromagnetics. 2006, 27 (3): 204-214. 10.1002/bem.20195.View ArticlePubMed
- Chu MK: Comment on 'Mobile phone headache: A double blind, sham-controlled provocation study'. Cephalalgia. 2010, 30 (6): 767-10.1177/0333102409352100.View ArticlePubMed
- Rubin GJ, Nieto Hernandez R, Wessely S: Idiopathic environmental intolerance attributed to electromagnetic fields (formerly 'electromagnetic hypersensitivity'): An updated systematic review of provocation studies. Bioelectromagnetics. 2010, 31 (1): 1-11.PubMed
- Olesen J, Steiner T, Bousser M: Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia. 2009, 29 (12): 1331-1336. 10.1111/j.1468-2982.2009.01965.x.View ArticlePubMed
- The World Medical Association's Declaration of Helsinki: Historical and Contemporary Perspectives, 5th draft. [http://www.wma.net/en/30publications/10policies/b3/index.html.pdf?print-media-type&footer-right=[page]/[toPage]]
- Lipton R, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W: A self-administered screener for migraine in primary care. Neurology. 2003, 61 (3): 375-382.View ArticlePubMed
- Sandstrom M, Wilen J, Hansson Mild K, Oftedal G: Mobile phone use and subjective symptoms. Comparison of symptoms experienced by users of analogue and digital mobile phones. Occupational Medicine. 2001, 51 (1): 25-35. 10.1093/occmed/51.1.25.View ArticlePubMed
- Al-Khlaiwi T, Meo SA: Association of mobile phone radiation with fatigue, headache, dizziness, tension and sleep disturbance in Saudi population. Saudi medical journal. 2004, 25: 732-736.PubMed
- Santini R, Seigne M, Bonhomme-Faivre L, Bouffet S, Defrasne E, Sage M: Symptoms reported by mobile cellular telephone users. Pathologie-biologie. 2001, 49 (3): 222-226. 10.1016/S0369-8114(01)00132-8.View ArticlePubMed
- Mortazavi S, Ahmadi J, Shariati M: Prevalence of subjective poor health symptoms associated with exposure to electromagnetic fields among university students. Bioelectromagnetics. 2007, 28 (4): 326-330. 10.1002/bem.20305.View ArticlePubMed
- Stovner L, Oftedal G, Straume A, Johnsson A: Nocebo as headache trigger: evidence from a sham controlled provocation study with RF fields. Acta Neurologica Scandinavica. 2008, 117: 67-71. 10.1111/j.1600-0404.2008.01035.x.View Article
- Hahn RA: The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health* 1. Preventive medicine. 1997, 26 (5): 607-611. 10.1006/pmed.1996.0124.View ArticlePubMed
- Rubin GJ, Cleare AJ, Wessely S: Psychological factors associated with self-reported sensitivity to mobile phones. Journal of psychosomatic research. 2008, 64 (1): 1-9. 10.1016/j.jpsychores.2007.05.006.View ArticlePubMed
- Oftedal G, Wilen J, Sandstrom M, Mild KH: Symptoms experienced in connection with mobile phone use. Occupational medicine. 2000, 50 (4): 237-View ArticlePubMed
- Straume A, Oftedal G, Johnsson A: Skin temperature increase caused by a mobile phone: a methodological infrared camera study. Bioelectromagnetics. 2005, 26 (6): 510-519. 10.1002/bem.20124.View ArticlePubMed
- Lee J, Yun C, Chu M, Ha C: Hot bath-related headache controlled by topiramate. Cephalalgia. 2007, 27 (5): 465-467. 10.1111/j.1468-2982.2007.01308.x.View ArticlePubMed
- Mahendra PKV, Sridhar V: The relationship between noise frequency components and physical, physiological and psychological effects of industrial workers. Noise & health. 2008, 10 (40): 90-98. 10.4103/1463-1741.44347.View Article
- Martin PR, Reece J, Forsyth M: Noise as a trigger for headaches: relationship between exposure and sensitivity. Headache: The Journal of Head and Face Pain. 2006, 46 (6): 962-972. 10.1111/j.1526-4610.2006.00468.x.View Article
- Mungen B, Bulut S: Hot bath-related headache: four cases with headaches occurring after taking a hot bath. Cephalalgia. 2003, 23 (8): 846-849. 10.1046/j.1468-2982.2003.00562.x.View ArticlePubMed
- Acar GO, Yener HM, Savrun FK, Kalkan T, Bayrak I, Enver O: Thermal effects of mobile phones on facial nerves and surrounding soft tissue. The Laryngoscope. 2009, 119 (3): 559-562. 10.1002/lary.20070.View ArticlePubMed
- Anderson V, Rowley J: Measurements of skin surface temperature during mobile phone use. Bioelectromagnetics. 2007, 28 (2): 159-162. 10.1002/bem.20282.View ArticlePubMed
- GSM. [http://en.wikipedia.org/wiki/Gsm]
- Olesen J, Bousser M, Diener H, Dodick D: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006, 26 (6): 742-746.View ArticlePubMed
- Aurora SK, Kulthia A, Barrodale PM: Mechanism of Chronic Migraine. Current pain and headache reports. 2011, 1-7.
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/11/115/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.